Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Disease Symptoms Equipment Supplied In Europe
21 equipment items found
Manufactured by:Bioprojet based inParis, FRANCE
Treatment of idiopathic or hereditary pulmonary hypertension in view of improving exercise tolerance and disease symptoms in New York Heart Association (NYHA) functional class III patients. ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Gaucher disease is the most common lysosomal storage disease and is caused by mutations in GBA, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme. These mutations result in the misfolding and subsequent dysfunction of GCase, which leads to the toxic buildup of fat in a variety of organs and tissues such as the liver, spleen, bones and central ...
Manufactured by:Pharmazeutische Fabrik Montavit based inAbsam, AUSTRIA
Tavipec capsules help for acute bronchitis, colds and ...
Manufactured by:H. Buschkühl GmbH based inErkrath, GERMANY
The treatment of Lyme disease with photons, avoiding antibiotics at the same time, is a standard therapy in many practices today. During a period of three years, 108 persons were treated under control in an observational study. The relapse rate amounts less than 5%, not excluding cases of reinfection. We have successfully treated far over 1000 patients within nine years. This ...
Manufactured by:HiberGene Diagnostics based inDublin, IRELAND
Neisseria meningitidis and Streptococcus pneumoniae cause up to 87% of bacterial meningitis cases in young children and adults¹. Bacterial meningitis is an aggressive disease with non-specific symptoms making it inherently difficult to diagnose. The disease is responsible for over 1.2 million cases and 170,000 deaths annually ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Morquio B, also known as Mucopolysaccharidosis type IV (MPS IV), is a progressive disease mostly impacting the skeleton, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of keratan sulfate in organs and tissues. Very ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to the toxic buildup of large sugars in the bone, cartilage, cornea, heart and central nervous system (CNS). There is currently no cure ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
i-Tracker Adalimumab is an automated assay intended for the quantitative measurement of Adalimumab (anti-TNFα agent) in human serum or plasma ...
Manufactured by:Endodiag based inParis, FRANCE
Endodiag together with several expert gynecologists has developed EndoGram, a 10-biomarker test based on the analysis of biopsies taken during surgery. Thanks to a proprietary algorithm combining other patient clinical factors, EndoGram provides for each patient a risk of disease recurrence score and a biological profile aimed to help the physician discard unsuitable treatments. EndoGram is ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
i-Tracker anti-Infliximab is an automated assay intended for the quantitative measurement of Anti-Infliximab antibodies (anti-drug antibodies: ADAb) in human serum or plasma ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
GM1 Gangliosidosis is a hereditary, progressive disease mostly impacting neurons in the brain and spinal cord, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of GM1 ganglioside in organs and tissues. Very limited and ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
LISA-TRACKER Duo Infliximab is an enzyme linked immunoassay (ELISA) for the quantitative determination of Infliximab (anti-TNFα) and anti-Infliximab antibodies in human serum ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The Mplex Monkeypox, Orthopox is a research use only (RUO) Real-time PCR assay designed for the simultaneous qualitative detection of the monkeypox virus and its differentiation from other orthopox viruses. Sample material should be DNA extracted from human upper respiratory specimen types, whole blood, serum or pustule specimen types. ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
i-Tracker anti-Adalimumab is an automated assay intended for the quantitative measurement of anti-Adalimumab antibodies (anti-drug antibodies: ADAb) in human serum or plasma ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
Research to develop new antibodies for treating neurodegenerative disorders is under way at BioArctic. the ND3014 project aims to develop selective antibody treatments targeting TDP-43, a protein that is believed to play a crucial role in the development of the rare neurodegenerative disease ALS (amyotrophic lateral ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
BioArctic has developed a technology platform that has proven to be successful when the company’s first drug candidate was developed, the antibody BAN2401 for Alzheimer´s disease. Our mission is to improve quality of life for patients suffering from Central Nervous System (CNS) disorders. Patients with neurodegenerative disorders like Alzheimer’s disease and Parkinson’s ...
Manufactured by:betaSENSE based in, GERMANY
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to detect minute changes between states of a sample by subtracting absorption spectra, thereby highlighting protein signals such as amyloid-beta and ...
Manufactured by:AB ANALITICA s.r.l. based inPADUA, ITALY
REALQUALITY RQ-CMV is a diagnostic CE-IVD kit for the identification and quantification of the DNA of Human Cytomegalovirus (CMV) by Real time PCR. ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
Microsomal prostaglandin E synthase (mPGES-1) is an enzyme generally present at low levels in the human body. It stimulates production of prostaglandin E2 (PGE2), a potent biological messenger that has a pronounced impact on inflammation. During inflammation the levels of mPGES-1 are upregulated, causing excessive levels of PGE2, which drive the inflammatory symptoms. ...
by:Pure Biologics SA based inWroclaw, POLAND
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the pharmaceutical industry. However, considerable social and institutional support exists for developing new therapies for such rare diseases. The PB002 ...